Glenmark Pharmaceuticals Ltd, a research-led global integrated pharmaceutical company, today announced that it has entered into a collaboration with leading, home-grown private equity firm True North for its orthopaedic and…Read More
Cipla Limited (Cipla) today announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Atazanavir Caps 100 mg, 150 mg, 200 mg, 300 mg from…Read More
Net profit of Alkem Laboratories rose 15.49% to Rs 129.49 crore in the quarter ended June 2018 as against Rs 112.12 crore during the previous quarter ended June 2017. Sales…Read More
Drugmaker Cadila Healthcare reported a three-fold jump year-on-year (Y-o-Y) in net profit to Rs 460.5 crore in the first quarter ended June due to higher sales in the US and…Read More
Cipla USA, Inc., a subsidiary of Cipla Limited, announced that it has secured rights from MSN Laboratories Private Limited to market & distribute Capecitabine 150 mg and 500 mg tablets…Read More
Glenmark Pharmaceuticals Limited, a research-led global integrated pharmaceutical company, announced its financial results for the first quarter ended June 30 of financial year 2018-19. For the first quarter ended June…Read More
Net profit of Bal Pharma rose 229.58% to Rs 2.34 crore in the quarter ended June 2018 as against Rs 0.71 crore during the previous quarter ended June 2017. Sales…Read More
The weightage of the pharmaceutical sector on the Nifty index is likely to drop to levels last seen after the Lehman crisis, analysts at ICICI Securities have written in a…Read More
Akums Drugs and Pharmaceuticals Ltd., one of India’s largest Contract Drug Research and Manufacturing Organizations (CRAMS), has won the prestigious Business Leadership Award at the National CSR Summit and Awards…Read More
India’s second largest drug manufacturer Aurobindo Pharmais likely to report a net profit of Rs 539 .5 crore for the first quarter of FY19, going by an average of estimates of…Read More
Pharma Major Lupin Limited reported its financial performance for the first quarter ending June 30th, 2018. These results were taken on record by the Board of Directors at a meeting…Read More
Glenmark Pharmaceuticals, a global pharmaceutical company, today announced that the U.S. Food & Drug Administration (FDA) has accepted for review the company’s New Drug Application for its leading respiratory pipeline…Read More
Cipla Limited announced its unaudited consolidated financial results for quarter ended June 30, 2018. Key highlights of the quarter: Financials: Strong YoY sales growth of 12% with EBITDA growing by 12%…Read More
Glenmark Pharmaceuticals’ partner Elite Pharmaceuticals has received approval from the U. S. Food and Drug Administration (FDA) for the abbreviated new drug application (ANDA) for methadone hydrochloride 5 mg and 10 mg tablets. Methadone is indicated for the management…Read More
Kilitch Drugs (India) Ltd, a fast growing pharmaceuticals company listed on NSE and BSE, today announced its plans to focus on African markets with a state-of-the-art Cephalosporin injectable plant near…Read More
Recent Comments